Literature DB >> 20513804

Allogeneic stem cell transplantation for acute myeloid leukemia.

Jacopo Peccatori, Fabio Ciceri.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20513804      PMCID： PMC2878779          DOI： 10.3324/haematol.2010.023184

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.

Authors:  E D THOMAS; H L LOCHTE; W C LU; J W FERREBEE
Journal:  N Engl J Med       Date:  1957-09-12       Impact factor: 91.245

2.  Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.

Authors:  Charles Craddock; Sandeep Nagra; Andrew Peniket; Cassandra Brookes; Laura Buckley; Emmanouil Nikolousis; Nick Duncan; Sudhir Tauro; John Yin; Effie Liakopoulou; Panos Kottaridis; John Snowden; Donald Milligan; Gordon Cook; Eleni Tholouli; Tim Littlewood; Karl Peggs; Paresh Vyas; Fiona Clark; Mark Cook; Stephen Mackinnon; Nigel Russell
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

3.  Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

Authors:  Franco Aversa; Adelmo Terenzi; Antonio Tabilio; Franca Falzetti; Alessandra Carotti; Stelvio Ballanti; Rita Felicini; Flavio Falcinelli; Andrea Velardi; Loredana Ruggeri; Teresa Aloisi; Jean Pierre Saab; Antonella Santucci; Katia Perruccio; Maria Paola Martelli; Cristina Mecucci; Yair Reisner; Massimo F Martelli
Journal:  J Clin Oncol       Date:  2005-03-07       Impact factor: 44.544

4.  High-dose daunorubicin in older patients with acute myeloid leukemia.

Authors:  Bob Löwenberg; Gert J Ossenkoppele; Wim van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Johan Maertens; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Marinus van Marwijk Kooy; Leo F Verdonck; Joachim Beck; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gregor Verhoef
Journal:  N Engl J Med       Date:  2009-09-24       Impact factor: 91.245

5.  Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

Authors:  Roberto Crocchiolo; Elisabetta Zino; Luca Vago; Rosi Oneto; Barbara Bruno; Simona Pollichieni; Nicoletta Sacchi; Maria Pia Sormani; Jessica Marcon; Teresa Lamparelli; Renato Fanin; Lucia Garbarino; Valeria Miotti; Giuseppe Bandini; Alberto Bosi; Fabio Ciceri; Andrea Bacigalupo; Katharina Fleischhauer
Journal:  Blood       Date:  2009-06-10       Impact factor: 22.113

6.  Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.

Authors:  Jeffrey Y C Wong; Joseph Rosenthal; An Liu; Timothy Schultheiss; Stephen Forman; George Somlo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-09       Impact factor: 7.038

7.  Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Authors:  Fabio Ciceri; Chiara Bonini; Maria Teresa Lupo Stanghellini; Attilio Bondanza; Catia Traversari; Monica Salomoni; Lucia Turchetto; Scialini Colombi; Massimo Bernardi; Jacopo Peccatori; Alessandra Pescarollo; Paolo Servida; Zulma Magnani; Serena K Perna; Veronica Valtolina; Fulvio Crippa; Luciano Callegaro; Elena Spoldi; Roberto Crocchiolo; Katharina Fleischhauer; Maurilio Ponzoni; Luca Vago; Silvano Rossini; Armando Santoro; Elisabetta Todisco; Jane Apperley; Eduardo Olavarria; Shimon Slavin; Eva M Weissinger; Arnold Ganser; Michael Stadler; Evangelia Yannaki; Athanasios Fassas; Achilles Anagnostopoulos; Marco Bregni; Corrado Gallo Stampino; Paolo Bruzzi; Claudio Bordignon
Journal:  Lancet Oncol       Date:  2009-04-01       Impact factor: 41.316

8.  A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.

Authors:  Fabio Ciceri; Myriam Labopin; Franco Aversa; Jakob M Rowe; Donald Bunjes; Philippe Lewalle; Arnon Nagler; Paolo Di Bartolomeo; João F Lacerda; Maria Teresa Lupo Stanghellini; Emmanuelle Polge; Francesco Frassoni; Massimo F Martelli; Vanderson Rocha
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

9.  Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.

Authors:  Wolfgang A Bethge; Christoph Faul; Martin Bornhäuser; Gernot Stuhler; Dietrich W Beelen; Peter Lang; Matthias Stelljes; Wichard Vogel; Matthias Hägele; Rupert Handgretinger; Lothar Kanz
Journal:  Blood Cells Mol Dis       Date:  2007-09-14       Impact factor: 3.039

Review 10.  Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.

Authors:  Margaret L MacMillan; Stella M Davies; Gene O Nelson; Pintip Chitphakdithai; Dennis L Confer; Roberta J King; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742
View more
  10 in total

1.  Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia.

Authors:  Elizabeth DiMaggio; Jun-Min Zhou; Ryan Caddell; Rebecca Tombleson; Janelle Perkins; Claudio Anasetti; Farhad Khimani; Joseph Pidala; Taiga Nishihori; Lia Perez; Brian Betts; Hugo F Fernandez; Asmita Mishra
Journal:  Leuk Lymphoma       Date:  2020-03-05

Review 2.  Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia.

Authors:  Y S Jethava; S Sica; B Savani; F Socola; M Jagasia; M Mohty; A Nagler; A Bacigalupo
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

3.  Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis.

Authors:  Dipenkumar Modi; Vijendra Singh; Seongho Kim; Lois Ayash; Abhinav Deol; Voravit Ratanatharathorn; Joseph P Uberti
Journal:  Ann Hematol       Date:  2021-02-16       Impact factor: 3.673

4.  Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines.

Authors:  Sol-Rim Jeon; Jae-Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho; Dae-Chul Jeong
Journal:  Blood Res       Date:  2015-03-24

5.  Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.

Authors:  Ivana Trajkovska; Borce Georgievski; Lidija Cevreska; Andrijana Gacovski; Taner Hasan; Natasha Nedeska-Minova
Journal:  Open Access Maced J Med Sci       Date:  2017-05-09

6.  Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study.

Authors:  Emilia Salzmann-Manrique; Melanie Bremm; Sabine Huenecke; Milena Stech; Andreas Orth; Matthias Eyrich; Ansgar Schulz; Ruth Esser; Thomas Klingebiel; Peter Bader; Eva Herrmann; Ulrike Koehl
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

7.  Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Authors:  Jing Zhu; Tejendra Patel; Jordan A Miller; Chad D Torrice; Mehak Aggarwal; Margaret R Sketch; Maurice D Alexander; Paul M Armistead; James M Coghill; Tatjana Grgic; Katarzyna J Jamieson; Jonathan R Ptachcinski; Marcie L Riches; Jonathan S Serody; John L Schmitz; J Ryan Shaw; Thomas C Shea; Oscar Suzuki; Benjamin G Vincent; William A Wood; Kamakshi V Rao; Tim Wiltshire; Eric T Weimer; Daniel J Crona
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 8.  Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.

Authors:  Jodi J Lipof; Kah Poh Loh; Kristen O'Dwyer; Jane L Liesveld
Journal:  Cancers (Basel)       Date:  2018-06-04       Impact factor: 6.639

Review 9.  The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective.

Authors:  Dimitrios Mougiakakos
Journal:  Front Oncol       Date:  2019-11-06       Impact factor: 6.244

10.  Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation.

Authors:  Angélica Cuapio; Mirte Post; Sabine Cerny-Reiterer; Karoline V Gleixner; Gabriele Stefanzl; Jose Basilio; Susanne Herndlhofer; Wolfgang R Sperr; Nicolaas H C Brons; Emilio Casanova; Jacques Zimmer; Peter Valent; Erhard Hofer
Journal:  Oncotarget       Date:  2016-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.